Factors associated with symptom response to pyloric injection of botulinum toxin in a large series of gastroparesis patients

Digestive Diseases and Sciences

Volumn 54, Issue 12, 2009, Pages 2634-2642

  Coleski, Radoslav ^a   Anderson, Michelle A ^a   Hasler, William L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Botulinum toxin; Diabetes mellitus; Gastric emptying; Gastroparesis; Nausea and vomiting

Indexed keywords

BOTULINUM TOXIN; OPIATE;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; REPEAT PROCEDURE; RETROSPECTIVE STUDY; SCINTIGRAPHY; STOMACH EMPTYING; STOMACH FUNCTION; STOMACH PARESIS; TREATMENT RESPONSE;

ADULT; ANALYSIS OF VARIANCE; BOTULINUM TOXINS; CHI-SQUARE DISTRIBUTION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GASTRIC EMPTYING; GASTROINTESTINAL AGENTS; GASTROPARESIS; HUMANS; INJECTIONS; LINEAR MODELS; LOGISTIC MODELS; MALE; MICHIGAN; MIDDLE AGED; PYLORUS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 70450235457     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0660-9     Document Type: Article

References (27)

1. HP Parkman WL Hasler RS Fisher 2004 American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis Gastroenterology 127 1592 1622 10.1053/j.gastro.2004.09.055 10.1053/j.gastro. 2004.09.055 15521026 (Pubitemid 39457783)
2. I Soykan B Sivri I Saroseik B Kiernan RW McCallum 1998 Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis Dig Dis Sci 43 2398 2404 10.1023/A:1026665728213 10.1023/A:1026665728213 1:STN:280:DyaK1M%2FjvFOgsw%3D%3D 9824125
3. V Annese J Janssens G Vantrappen, et al. 1992 Erythromycin accelerates gastric emptying by inducing antral contractions and improved gastroduodenal coordination Gastroenterology 102 823 828 1:CAS:528:DyaK38Xhs1Kjt7c%3D 1537520
4. F Mearin M Camilleri JR Malagelada 1986 Pyloric dysfunction in diabetics with recurrent nausea and vomiting Gastroenterology 90 1919 1925 1:STN:280:DyaL287ptlGjsA%3D%3D 3699409
5. C Montecucco G Schiavo 1994 Mechanism of action of tetanus and botulinum neurotoxins Mol Microbiol 13 1 8 10.1111/j.1365-2958.1994.tb00396.x 10.1111/j.1365-2958.1994.tb00396.x 1:CAS:528:DyaK2cXlt1Oitr4%3D 7527117 (Pubitemid 24220537)
6. P Gupta SS Rao 2002 Attenuation of isolated pyloric pressure waves in gastroparesis in response to botulinum toxin injection: a case report Gastrointest Endosc 56 770 772 10.1016/S0016-5107(02)70140-5 10.1016/S0016-5107(02)70140-5 12397299 (Pubitemid 36531726)
7. D Ezzeddine R Jit N Katz N Gopalswamy MS Bhutani 2002 Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis Gastrointest Endosc 55 920 923 10.1067/mge.2002.124739 10.1067/mge.2002.124739 12024156 (Pubitemid 41127918)
8. LS Miller GA Szych SB Kantor, et al. 2002 Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle Am J Gastroenterol 97 1653 1660 10.1111/j.1572-0241.2002.05823.x 10.1111/j.1572-0241.2002.05823.x 1:CAS:528:DC%2BD38Xmt1Sit7w%3D 12135014
9. BE Lacy EN Zayat MD Crowell MM Schuster 2002 Botulinum toxin for the treatment of gastroparesis: a preliminary report Am J Gastroenterol 97 1548 1552 10.1111/j.1572-0241.2002.05741.x 10.1111/j.1572-0241.2002.05741.x 1:CAS:528:DC%2BD2MXjtFOqtrg%3D 12094882
10. BE Lacy MD Crowell A Schettler-Duncan C Mathis PJ Pasricha 2004 The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus Diabetes Care 27 2341 2347 10.2337/diacare.27.10.2341 10.2337/diacare.27.10.2341 1:CAS:528:DC%2BD2cXovFOmtbw%3D 15451898 (Pubitemid 39281383)
11. J Arts S Van Gool P Caenepeel K Verbeke J Janssens J Tack 2006 Influence of intrapyloric botulinum toxin injection of gastric emptying and meal-related symptoms in gastroparesis patients Aliment Pharmacol Ther 24 661 667 10.1111/j.1365-2036.2006.03019.x 10.1111/j.1365-2036.2006.03019.x 1:CAS:528:DC%2BD28XpslWjsLc%3D 16907899 (Pubitemid 44127848)
12. PH Wiesel R Schneider G Dorta AL Blum M Gillet P Michetti 1997 Botulinum toxin for refractory postoperative pyloric spasm Endoscopy 29 132 10.1055/s-2007-1004091 10.1055/s-2007-1004091 1:STN:280:DyaK2s3lsFyhtg%3D%3D 9101155
13. MQ Bromer F Friedenberg LS Miller RS Fisher K Swartz HP Parkman 2005 Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis Gastrointest Endosc 61 833 839 10.1016/S0016-5107(05) 00328-7 10.1016/S0016-5107(05)00328-7 15933684 (Pubitemid 40779413)
14. R Ben-Youssef PW Baron E Franco MH Walter T Lewis O Ojogho 2006 Intrapyloric injection of botulinum toxin A for the treatment of persistent gastroparesis following successful pancreatic transplantation Am J Transplant 6 214 218 10.1111/j.1600-6143.2005.01153.x 10.1111/j.1600-6143.2005.01153.x 1:STN:280:DC%2BD28%2FksFSisw%3D%3D 16433778 (Pubitemid 43382222)
15. MS Kent A Pennathur T Fabian A McKelvey MJ Schuchert JD Luketich RJ Landreneau 2007 A pilot study of botulinum toxin injection for the treatment of delayed gastric emptying following esophagectomy Surg Endosc 21 754 757 10.1007/s00464-007-9225-9 10.1007/s00464-007-9225-9 1:STN:280: DC%2BD2s3ltVCgsg%3D%3D 17458616 (Pubitemid 46675518)
16. FK Friedenberg A Palit HP Parkman A Hanlon DB Nelson 2008 Botulinum toxin A for the treatment of delayed gastric emptying Am J Gastroenterol 103 416 423 10.1111/j.1572-0241.2007.01676.x 10.1111/j.1572-0241.2007.01676.x 1:CAS:528:DC%2BD1cXjtVOgtLk%3D 18070232 (Pubitemid 351248749)
17. J Arts L Holvoet P Caenepeel, et al. 2007 Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis Aliment Pharmacol Ther 26 1251 1258 1:CAS:528: DC%2BD2sXhtlyrsbfI 17944739
18. G Schiavo CC Shone O Rossetto FC Alexander C Montecucco 1993 Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin J Biol Chem 268 11516 11519 1:CAS:528:DyaK3sXks1Ggtrc%3D 8505288
19. YP Hou YP Zhang YF Song CM Zhu YC Wang GL Xie 2007 Botulinum toxin type A inhibits rat pyloric myoelectrical activity and substance P release in vivo Can J Physiol Pharmacol 85 209 214 10.1139/Y07-018 10.1139/Y07-018 1:CAS:528:DC%2BD2sXmsVWntL8%3D 17487262 (Pubitemid 46846432)
20. DA De Looze HG Verdievel TL Peeters MM De Vos 2000 The pyloric sphincter is back in town Gastroenterology 118 A468 abstract
21. CP Harris K Alderson J Nebeker JB Holds RL Anderson 1991 Histologic features of human orbicularis oculi treated with botulinum A toxin Arch Ophthalmol 109 393 395 1:STN:280:DyaK3M7ms1CksA%3D%3D 2003801
22. AJ Bredenoord HJ Chial M Camilleri BP Mullan JA Murray 2003 Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms Clin Gastroenterol Hepatol 1 264 272 10.1016/S1542-3565(03)00130-7 10.1016/S1542-3565(03)00130-7 15017667 (Pubitemid 37254453)
23. M Samsom GA Salet JM Roelofs LM Akkermans GP Van Berge Henegouwen AJ Smout 1995 Compliance of the proximal stomach and dyspeptic symptoms in patients with type I diabetes mellitus Dig Dis Sci 40 2037 2042 10.1007/BF02208676 10.1007/BF02208676 1:STN:280:DyaK28%2FivFamtQ%3D%3D 7555462
24. M Samsom JM Roelofs LM Akkermans GP Van Berge Henegouwen AJ Smout 1998 Proximal gastric motor activity in response to a liquid meal in type I diabetes mellitus with autonomic neuropathy Dig Dis Sci 43 491 496 10.1023/A: 1018894520557 10.1023/A:1018894520557 1:STN:280:DyaK1c7pvFSmsg%3D%3D 9539642 (Pubitemid 28155568)
25. M Camilleri JR Malagelada 1984 Abnormal intestinal motility in diabetics with the gastroparesis syndrome Eur J Clin Invest 14 420 427 10.1111/j.1365-2362.1984.tb01206.x 10.1111/j.1365-2362.1984.tb01206.x 1:STN:280:DyaL2M7islWktg%3D%3D 6441717
26. E Bizer S Harrell J Koopman C Hatfield R Cacchione JM Wo 2005 Obesity is common in gastroparesis despite nausea, vomiting, and early satiety Gastroenterology 128 M1895 abstract
27. J Jankovic 1994 Botulinum toxin in movement disorders Curr Opin Neurol 7 358 366 10.1097/00019052-199408000-00014 1:STN:280:DyaK2M%2FjvF2lsg%3D%3D 7952246